IMVT filings
Corporate insider profile
Andrew J. Fromkin Filing Activity
Latest reported as Corporate insider of Immunovant, Inc. (IMVT).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$7,438,110.69
- Latest transaction
- May 28, 2026
Affiliated corporations
Reported company relationships
Transaction history